These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 11707242)

  • 1. [Therapeutic approaches in symptomatic hypertrophic obstructive cardiomyopathy].
    Montijano Cabrera AM; Bouzas Zubeldía B; Penas Lado M; McKenna WJ
    Rev Esp Cardiol; 2001 Nov; 54(11):1311-26. PubMed ID: 11707242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hypertrophic obstructive cardiomyopathy: current treatment, indications and results].
    Delahaye JP; Azzano O
    Presse Med; 1994 May; 23(20):925-7. PubMed ID: 7937627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertrophic obstructive cardiomyopathy: mechanism of obstruction and response to therapy.
    Yoerger DM; Weyman AE
    Rev Cardiovasc Med; 2003; 4(4):199-215. PubMed ID: 14668688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hypertrophic cardiomyopathy (HCM). Surgical versus drug therapy].
    Schulte HD; Gramsch-Zabel H; Schwartzkopff B; Gams E
    Z Kardiol; 1999 Mar; 88(3):163-72. PubMed ID: 10355066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Aspects of treatment of hypertrophic obstructive cardiomyopathy with emphasis on the role of percutaneous transluminal ablation of the myocardial septum].
    Veselka J
    Vnitr Lek; 2001 Dec; 47(12):887-91. PubMed ID: 11826555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of hypertrophic cardiomyopathy in children.
    Seggewiss H; Rigopoulos A
    Paediatr Drugs; 2003; 5(10):663-72. PubMed ID: 14510624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a review of the literature.
    Veselka J
    Med Sci Monit; 2007 Apr; 13(4):RA62-8. PubMed ID: 17392660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic management of hypertrophic obstructive cardiomyopathy: alcohol septal ablation or surgical myomectomy?
    Noble S; Sigwart U
    Expert Rev Cardiovasc Ther; 2014 Sep; 12(9):1041-4. PubMed ID: 25039895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertrophic Obstructive Cardiomyopathy: Surgical Myectomy and Septal Ablation.
    Nishimura RA; Seggewiss H; Schaff HV
    Circ Res; 2017 Sep; 121(7):771-783. PubMed ID: 28912182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Who and how to treat with non-surgical myocardial reduction therapy in hypertrophic cardiomyopathy: long-term outcomes.
    Martin WA; Sigwart U
    Heart Fail Monit; 2002; 3(1):15-27. PubMed ID: 12634884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and beta-adrenergic blocker therapy.
    Fananapazir L; Cannon RO; Tripodi D; Panza JA
    Circulation; 1992 Jun; 85(6):2149-61. PubMed ID: 1350522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symptomatic hypertrophic obstructive cardiomyopathy: the role of dual-chamber pacing.
    Park MH; Gilligan DM; Bernardo NL; Topaz O
    Angiology; 1999 Feb; 50(2):87-94. PubMed ID: 10063938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-lasting improvement after septal myectomy for hypertrophic obstructive cardiomyopathy.
    Merrill WH; Friesinger GC; Graham TP; Byrd BF; Drinkwater DC; Christian KG; Bender HW
    Ann Thorac Surg; 2000 Jun; 69(6):1732-5; discussion 1735-6. PubMed ID: 10892916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
    Sorajja P; Valeti U; Nishimura RA; Ommen SR; Rihal CS; Gersh BJ; Hodge DO; Schaff HV; Holmes DR
    Circulation; 2008 Jul; 118(2):131-9. PubMed ID: 18591440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current respective role of surgery and permanent endocavitary stimulation in the treatment of hypertrophic cardiomyopathies].
    Millaire A; de Groote P; Decoulx E; Ducloux G
    Ann Cardiol Angeiol (Paris); 1995 May; 44(5):226-33. PubMed ID: 7639504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients.
    Seggewiss H; Gleichmann U; Faber L; Fassbender D; Schmidt HK; Strick S
    J Am Coll Cardiol; 1998 Feb; 31(2):252-8. PubMed ID: 9462563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical pathology of subaortic septal myectomy: histology skips over clinical diagnosis.
    Abecasis J; Gouveia R; Castro M; Andrade MJ; Ribeiras R; Ramos S; Abecasis M; Cardim N; Gil V
    Cardiovasc Pathol; 2018; 33():32-38. PubMed ID: 29414430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DDD pacing in hypertrophic cardiomyopathy: a multicentre clinical experience.
    Slade AK; Sadoul N; Shapiro L; Chojnowska L; Simon JP; Saumarez RC; Dodinot B; Camm AJ; McKenna WJ; Aliot E
    Heart; 1996 Jan; 75(1):44-9. PubMed ID: 8624871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection of hypertrophic cardiomyopathy patients for myectomy or alcohol septal ablation.
    Lever HM
    Anadolu Kardiyol Derg; 2006 Dec; 6 Suppl 2():27-30. PubMed ID: 17162266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended myectomy for hypertrophic obstructive cardiomyopathy after failure or contraindication of septal ablation or with combined surgical procedures.
    Dörge H; Schmitto JD; Liakopoulos OJ; Walther S; Schöndube FA
    Thorac Cardiovasc Surg; 2004 Dec; 52(6):344-8. PubMed ID: 15573275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.